Those side agreements will fall along with the overall trade pact.    antitrade politics aside, the biggest hurdle to Republicans ’ consideration of the Pacific pact was objections from some  —   led by Senator Orrin G. Hatch of Utah, chairman of the committee responsible for trade   —   to   provisions that would have limited monopoly protections for   pharmaceutical companies’   biologics. 